The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients
2010 · BMC Gastroenterology · 24 citations
https://doi.org/10.1186/1471-230x-10-26
M
Marisa Iborra
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
65
Papers
573
Citations
11
h-index
12
i10-index
Marisa Iborra is an academic researcher from Hospital Universitari i Politècnic La Fe. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Autoimmune and Inflammatory Disorders. The author has an h-index of 11, co-authored 56 publications.
ORCID: 0000-0003-2416-3560Papers by this author
worksRelationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved
2021 · Biomedicine & Pharmacotherapy · 15 citations
https://doi.org/10.1016/j.biopha.2021.112239
Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort
2023 · Scandinavian Journal of Gastroenterology · 12 citations
https://doi.org/10.1080/00365521.2023.2278427
Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.24516622
Efficacy of Beclomethasone Dipropionate in Lowering Fecal Calprotectin Levels in Patients with Ulcerative Colitis in Clinical Remission and at Risk of Relapse: The Becalcu Randomized, Controlled Trial
2024 · Digestive Diseases · 0 citations
https://doi.org/10.1159/000540792
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat